OBJECTIVE: To describe the rates of several key outcomes and healthcare-associated infections (HAIs) among hospitals that participated in the Duke Infection Control Outreach Network (DICON). DESIGN AND SETTING: Prospective, observational cohort study of patients admitted to 24 community hospitals from 2003 through 2009. METHODS: The following data were collected and analyzed: incidence of central line-associated bloodstream infections (CLABSIs), ventilator-associated pneumonia (VAP), catheter-associated urinary tract infections (CAUTIs), and HAIs caused by methicillin-resistant Staphylococcus aureus (MRSA); employee exposures to bloodborne pathogens (EBBPs); physician EBBPs; patient-days; central line-days; ventilator-days; and urinary catheter-days. Poisson regression was used to determine whether incidence rates of these HAIs and exposures changed during the first 5 and 7 years of participation in DICON; nonrandom clustering of each outcome was controlled for. Cost saved and lives saved were calculated on the basis of published estimates. RESULTS: In total, we analyzed 6.5 million patient-days, 4,783 EBPPs, 2,948 HAIs due to MRSA, and 2,076 device-related infections. Rates of employee EBBPs, HAIs due to MRSA, and device-related infections decreased significantly during the first 5 years of participation in DICON (P< .05 for all models; average decrease was approximately 50%); in contrast, physician EBBPs remained unchanged. In aggregate, 210 CLABSIs, 312 cases of VAP, 332 CAUTIs, 1,042 HAIs due to MRSA, and 1,016 employee EBBPs were prevented. Each hospital saved approximately $100,000 per year of participation, and collectively the hospitals may have prevented 52-105 deaths from CLABSI or VAP. The 7-year analysis demonstrated that these trends continued with further participation. CONCLUSIONS: Hospitals with long-term participation in an infection control network decreased rates of significant HAIs by approximately 50%, decreased costs, and saved lives.
OBJECTIVE: To describe the rates of several key outcomes and healthcare-associated infections (HAIs) among hospitals that participated in the Duke Infection Control Outreach Network (DICON). DESIGN AND SETTING: Prospective, observational cohort study of patients admitted to 24 community hospitals from 2003 through 2009. METHODS: The following data were collected and analyzed: incidence of central line-associated bloodstream infections (CLABSIs), ventilator-associated pneumonia (VAP), catheter-associated urinary tract infections (CAUTIs), and HAIs caused by methicillin-resistant Staphylococcus aureus (MRSA); employee exposures to bloodborne pathogens (EBBPs); physician EBBPs; patient-days; central line-days; ventilator-days; and urinary catheter-days. Poisson regression was used to determine whether incidence rates of these HAIs and exposures changed during the first 5 and 7 years of participation in DICON; nonrandom clustering of each outcome was controlled for. Cost saved and lives saved were calculated on the basis of published estimates. RESULTS: In total, we analyzed 6.5 million patient-days, 4,783 EBPPs, 2,948 HAIs due to MRSA, and 2,076 device-related infections. Rates of employee EBBPs, HAIs due to MRSA, and device-related infections decreased significantly during the first 5 years of participation in DICON (P< .05 for all models; average decrease was approximately 50%); in contrast, physician EBBPs remained unchanged. In aggregate, 210 CLABSIs, 312 cases of VAP, 332 CAUTIs, 1,042 HAIs due to MRSA, and 1,016 employee EBBPs were prevented. Each hospital saved approximately $100,000 per year of participation, and collectively the hospitals may have prevented 52-105 deaths from CLABSI or VAP. The 7-year analysis demonstrated that these trends continued with further participation. CONCLUSIONS: Hospitals with long-term participation in an infection control network decreased rates of significant HAIs by approximately 50%, decreased costs, and saved lives.
Authors: Matthew E Wise; R Douglas Scott; James M Baggs; Jonathan R Edwards; Katherine D Ellingson; Scott K Fridkin; L Clifford McDonald; John A Jernigan Journal: Infect Control Hosp Epidemiol Date: 2013-04-18 Impact factor: 3.254
Authors: Joshua T Thaden; Sarah S Lewis; Kevin C Hazen; Kirk Huslage; Vance G Fowler; Rebekah W Moehring; Luke F Chen; Constance D Jones; Zack S Moore; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2014-06-20 Impact factor: 3.254
Authors: Michael J Durkin; Kristen V Dicks; Arthur W Baker; Sarah S Lewis; Rebekah W Moehring; Luke F Chen; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2015-05-26 Impact factor: 3.254
Authors: Rebekah W Moehring; Kevin C Hazen; Myra R Hawkins; Richard H Drew; Daniel J Sexton; Deverick J Anderson Journal: J Clin Microbiol Date: 2015-07-15 Impact factor: 5.948
Authors: Michael J Durkin; Arthur W Baker; Kristen V Dicks; Sarah S Lewis; Luke F Chen; Deverick J Anderson; Daniel J Sexton; Rebekah W Moehring Journal: Infect Control Hosp Epidemiol Date: 2015-02 Impact factor: 3.254
Authors: Arthur W Baker; Salah Haridy; Joseph Salem; Iulian Ilieş; Awatef O Ergai; Aven Samareh; Nicholas Andrianas; James C Benneyan; Daniel J Sexton; Deverick J Anderson Journal: BMJ Qual Saf Date: 2017-11-24 Impact factor: 7.035
Authors: Sarah S Lewis; Rebekah W Moehring; Luke F Chen; Daniel J Sexton; Deverick J Anderson Journal: Infect Control Hosp Epidemiol Date: 2013-11 Impact factor: 3.254
Authors: Kristen V Dicks; Arthur W Baker; Michael J Durkin; Sarah S Lewis; Rebekah W Moehring; Deverick J Anderson; Daniel J Sexton; Luke F Chen Journal: Infect Control Hosp Epidemiol Date: 2015-04 Impact factor: 3.254